Obtained First-Class Pharmaceutical Manufacturing and Sales License and First-Class Medical Device Manufacturing and Sales License

CUES Consulting Inc. is pleased to announce that it has obtained the “First-Class Pharmaceutical Manufacturing and Sales License” on November 7, 2024, and the “First-Class Medical Device Manufacturing and Sales License” on November 20, 2024, from the Tokyo Metropolitan Government.

With these licenses, we have established a more reliable and legal foundation for our pharmaceutical and medical device manufacturing and sales operations. This enables us to provide high-level expertise and comprehensive support to our domestic and international clients. We are now better equipped to support the entire lifecycle of pharmaceuticals and medical devices, from development to manufacturing and sales.

In particular, we offer swift and flexible solutions for overseas pharmaceutical companies looking to enter the Japanese market or establish sales bases. We have also set up a system to respond to consultations regarding Designated Marketing Authorization Holders (DMAH) for pharmaceuticals and medical devices.

CUES Consulting will continue to respond accurately to changing market needs and strive to contribute to the development of the pharmaceutical industry and the health of people. We appreciate your continued support.